Board Meeting25 Jul 2026, 01:31 pm
GKB Ophthalmics Ltd Board Meeting on Aug 12 to Approve Q1 FY27 Results
AI Summary
GKB Ophthalmics Ltd has announced that its Board of Directors will convene on August 12, 2026. The primary agenda item is to consider and approve the unaudited standalone and consolidated financial results for the quarter ended June 30, 2026. The company has also informed that the trading window for designated persons, which was closed from July 01, 2026, will reopen 48 hours after the submission of these financial results to the stock exchange. This notice adheres to SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Key Highlights
- Board meeting scheduled for August 12, 2026.
- To approve unaudited standalone and consolidated financial results.
- Results are for the quarter ended June 30, 2026.
- Trading window to reopen post-results submission.
- Notice issued as per SEBI Listing Obligations and Disclosure Requirements.
Price Impact
More from GKB